Integrity Alliance’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.28M Buy
24,957
+473
+2% +$102K 0.2% 111
2026
Q1
$5.33M Sell
24,484
-501
-2% -$111K 0.2% 109
2025
Q4
$5.71M Buy
24,985
+10,918
+78% +$2.49M 0.21% 109
2025
Q3
$3.26M Buy
14,067
+991
+8% +$202K 0.15% 123
2025
Q2
$2.43M Sell
13,076
-9,726
-43% -$1.81M 0.13% 131
2025
Q1
$4.78M Buy
22,802
+20,680
+975% +$4.02M 0.19% 106
2024
Q4
$377K Buy
+2,122
New +$390K 0.04% 159

Other funds holding ABBV

Integrity Alliance's ABBV Position: Q2 2026 in Review

Integrity Alliance increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $102K and bringing the position to 24,957 shares worth $6.28M. The position accounts for 0.2% of the portfolio, ranked #111.

Integrity Alliance first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Integrity Alliance held 24,957 shares of AbbVie worth $6.28M as of Q2 2026.
  • Integrity Alliance bought 473 AbbVie shares in Q2 2026, an estimated $102K.
  • AbbVie made up 0.2% of Integrity Alliance's portfolio in Q2 2026, its #111 holding.
  • Integrity Alliance first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.